Soon Hin How

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

Yi‐Long Wu, Caicun Zhou, Chong Kin Liam et al. · Annals of Oncology · 2015 · 726 citations

Medicine, Phase Iii, Pathology +7

Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301

Byoung Chul Cho, Myung‐Ju Ahn, Jin Hyoung Kang et al. · Journal of Clinical Oncology · 2023 · 122 citations · Full text

Awareness, knowledge and attitude toward informed consent among doctors in two different cultures in Asia: a cross-sectional comparative study in Malaysia and Kashmir, India.

R M Yousuf, A R M Fauzi, Soon Hin How et al. · PubMed · 2007 · 61 citations

Outbreak of melioidosis and leptospirosis co-infection following a rescue operation.

Mohd Hanafi Sapian, Mohamed Khair, Soon Hin How et al. · PubMed · 2012 · 44 citations

Rescue Operation, Lubuk Yu, Emerging Infectious Diseases +14